254 related articles for article (PubMed ID: 11474882)
1. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
3. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
4. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
Parwani AV; Ali SZ
Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in prostatic malignancy.
di Sant'Agnese PA; Cockett AT
Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC; Veeramani S; Lin MF
Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
[TBL] [Abstract][Full Text] [Related]
7. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
8. [Small cell carcinoma of the prostate: a case report].
Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
[TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
Matsumoto Y; Mibu H; Kagebayashi Y
Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
[TBL] [Abstract][Full Text] [Related]
10. [A case of prostatic small cell carcinoma].
Hashimoto Y; Kimura G; Tsuboi N; Akimoto M
Hinyokika Kiyo; 2000 Jun; 46(6):425-7. PubMed ID: 10934615
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
Bonkhoff H
Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
[TBL] [Abstract][Full Text] [Related]
12. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
Miyoshi Y; Inoue Y; Matsuzaki J; Fukuda M; Satomi Y; Akahane H; Saito S
Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
[TBL] [Abstract][Full Text] [Related]
13. New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
Sciarra A; Cardi A; Dattilo C; Mariotti G; Di Monaco F; Di Silverio F
Int J Clin Pract; 2006 Apr; 60(4):462-70. PubMed ID: 16620361
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
[TBL] [Abstract][Full Text] [Related]
15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
[TBL] [Abstract][Full Text] [Related]
17. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
18. Unusual prostate carcinoma characterized by extensive metastasis, significantly increased serum level of prostatic-specific antigen,and neuroendocrine differentiation: a case report.
Hu YX; Ye J; Jiang Y; Zhang QF; Wu YL; Chen YY
Chin Med J (Engl); 2005 Feb; 118(3):258-61. PubMed ID: 15740661
[No Abstract] [Full Text] [Related]
19. Divergent neuroendocrine differentiation in prostatic carcinoma.
di Sant' Agnese PA
Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of histological types of prostatic cancer].
Medvedev VL; Matsionis AE; Medvedeva LA
Urologiia; 2003; (6):10-4. PubMed ID: 14708236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
